Neil Goldman Net Worth

The estimated Net Worth of Neil A Goldman is at least $354 mil dollars as of 13 February 2018. Mr. Goldman owns over 14,815 units of Chembio Diagnostics stock worth over $6,815 and over the last 7 years he sold CEMI stock worth over $0. In addition, he makes $346,936 as Chief Financial Officer y Executive Vice President at Chembio Diagnostics.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Goldman CEMI stock SEC Form 4 insiders trading

Neil has made over 1 trades of the Chembio Diagnostics stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 14,815 units of CEMI stock worth $100,001 on 13 February 2018.

The largest trade he's ever made was buying 14,815 units of Chembio Diagnostics stock on 13 February 2018 worth over $100,001. On average, Neil trades about 3,704 units every 0 days since 2018. As of 13 February 2018 he still owns at least 14,815 units of Chembio Diagnostics stock.

You can see the complete history of Mr. Goldman stock trades at the bottom of the page.

Neil Goldman biography

Neil A. Goldman has been appointed as Chief Financial Officer, Executive Vice President of the company. Executive Vice President and Chief Financial Officer since December 2017 • Executive Vice President-Corporate Development and Chief Financial Officer at J.S. Held LLC, a consulting and project management firm, from May 2015 to November 2017 • Finance Director for the Delphi Data Connectivity division of Delphi Corp., an automotive supplier, from October 2014 to April 2015 • Executive Vice President-Corporate Development and CFO from 2013 to September 2014, Senior Vice President-Chief Operating and Financial Officer from 2006 to 2013, and Chief Financial Officer from 2005 to 2006 at Unwired Technology LLC, an electronic communications equipment distributor, Chief Financial Officer at EPPCO Enterprises, a mechanics tools manufacturer, from 2003 to 2005 and He is Certified Public Accountant. He holds Bachelor of Science degree in Business-Accountancy from Miami (Ohio) University.

What is the salary of Neil Goldman?

As the Chief Financial Officer y Executive Vice President of Chembio Diagnostics, the total compensation of Neil Goldman at Chembio Diagnostics is $346,936. There are 3 executives at Chembio Diagnostics getting paid more, with Javan Esfandiari having the highest compensation of $557,521.

How old is Neil Goldman?

Neil Goldman is 52, he's been the Chief Financial Officer y Executive Vice President of Chembio Diagnostics since 2017. There are 6 older and no younger executives at Chembio Diagnostics. The oldest executive at Chembio Diagnostics Inc. is Mary Polan, 76, who is the Independent Director.

What's Neil Goldman's mailing address?

Neil's mailing address filed with the SEC is C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE, NY, 11788.

Insiders trading at Chembio Diagnostics

Over the last 20 years, insiders at Chembio Diagnostics have traded over $909,824 worth of Chembio Diagnostics stock and bought 3,754,893 units worth $1,696,058 . The most active insiders traders include Credit Advisors, Llcpercept..., Lawrence A. Siebert y Richard Eberly. On average, Chembio Diagnostics executives and independent directors trade stock every 90 days with the average trade being worth of $36,203. The most recent stock trade was executed by Credit Advisors, Llcpercept... on 21 April 2023, trading 243,448 units of CEMI stock currently worth $109,552.

What does Chembio Diagnostics do?

Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.

Complete history of Mr. Goldman stock trades at Chembio Diagnostics

Chembio Diagnostics executives and stock owners

Chembio Diagnostics executives and other stock owners filed with the SEC include:

• Javan Esfandiari,
  Exec. VP and Chief Science & Technology Officer
• Richard L. Eberly,
  Pres, CEO & Director
• Javan Esfandiari,
  Executive Vice President, Chief Scientific And Technology Officer
• Neil Goldman,
  Chief Financial Officer, Executive Vice President
• Katherine Davis,
  Independent Director
• John Potthoff,
  Independent Director
• Gail Page,
  Executive Chairman of the Board
• Mary Polan,
  Independent Director
• Lynn Lewis,
  Investor Relations Contact Officer
• Chuck Caso,
  Vice President of Sales and Marketing for North America
• Richard Eberly,
  President, Chief Executive Officer, Director
• Stella Rivera,
  VP of HR
• Atif Rizvi,
  VP of Fin.
• Dr. Konstantin Lyashchenko,
  Research Director of Chembio Diagnostic Systems Inc
• Charles Caso,
  VP of Sales & Marketing
• Paul J. Angelico,
  VP of Global Operations
• Peter Kissinger,
  Director
• Richard J Larkin,
  Chief Financial Officer
• Barbara A De Buono,
  Director
• John J Iii Sperzel,
  CEO
• Robert L Aromando,
  Sr VP, Commercial Operations
• Alan Carus,
  Director
• Lawrence A. Siebert,
  President
• Leslie Teso Lichtman,
  
• Norman H Pessin Brian L. Pe...,
  
• Gary Meller,
  Director
• Sharon W Klugewicz,
  Chief Operating Officer
• David Gyorke,
  See Remarks
• Robert Passas,
  See Remarks
• Avi Pelossof,
  Vice President
• Gerald A Eppner,
  Director
• James D Merselis,
  Director
• Capital Master Llc Crestvie...,
  
• David Acheson,
  
• Credit Advisors, Llcpercept...,
  
• David William Bespalko,
  
• Lawrence J. Steenvoorden,
  See remarks
• Charles Caso,
  See Remarks
• Paul Angelico,
  See remarks